Postdoc Researcher | Targeted Protein Degradation | University of California San Diego
Chemical Biology - Plant hormone signaling - Drug Discovery - Targeted Protein Degradation
Organic/Medical chemist in CeTPD (ACBI collaboration)
Associate professor of theoretical chemistry at University of Modena and Reggio Emilia. Interested in molecular simulations, catalysis, reactivity.
We are the largest biomedical science hub in the south of Europe, by the beach in Barcelona.
Recerca biomèdica amb vistes |
@researchmar.bsky.social @crg.eu @upf.edu @embl.org @isglobal.org @ibe-barcelona.bsky.social @fpmaragall.bsky.social
Chemical Biologist. Tenure track assistant prof @EPFL. Trying to make sense of the world by changing one variable at a time. https://www.epfl.ch/labs/libn/
The Society for Medicines Research is a UK based charity connecting scientists engaged in drug discovery. We organise scientific mentoring events.
https://smr.org.uk
Biotech Exec, Mom, TPD & Induced Proximity Science Nerd 🤓, Biophysicist, Outdoor Adventurer, Avid Traveler 🌻
Head of Computational Structural Biology Lab @pasteur.fr. ERC-CoG 2022. Research Director DR2 @cnrs.bsky.social. Founder/developer @plumed.org
Drug developer | Co-founder of Gate Bio | Fmr Big Pharma | Inventing small molecule medicines | Artist | Polymath
Exploring #ComputationalBiology & #Bioinformatics + Documenting my learning journey | Built by @noureldenrihan.bsky.social | 🌐 djosergenomics.github.io
The ISCB Regulatory and Systems Genomics Community of Special Interest (RegSys COSI) focuses on computational methods for studying gene/systems regulation
http://cosi.iscb.org/wiki/RegSIG:Home
Group Leader, Induced Proximity Therapeutics, Centre for Protein Degradation, Institute of Cancer Research, London
Chemical innovation for CNS diseases
VP & Head of Induced Proximity Platform, @Amgen | Scientist | Father
Celebrating the achievements and discoveries made by the brilliant women in targeted protein degradation and induced proximity!
Professor and Head of the Division of Molecular Therapeutics in MCB, UC Berkeley
Founder, Nurix and Lyterian Therapeutics
Excited about stress responses, ubiquitin, proteasome, targeted protein degradation, drug discovery
Professor @UniBonn. Former @DanaFarber @harvardmed | Targeted Protein Degradation | Chemical and Structural Biology | @UniofOxford alumni. Tweets are my own.
